Proactive News round-up: SkinBioTherapeutics, Alpha Growth, Afarak….


A selection of the stories appearing today on the Proactive websiteSkinBioTherapeutics PLC, a life science company focused on skin health, has launched a probiotic food supplement to help alleviate the symptoms associated with psoriasis.

Alpha Growth PLC (LSE:ALGW, OTCQB:ALPGF), the specialist fund manager, reported a loss for the half year to 31 August 2021 of GBP494,898 (2020 (audited): GBP567,200). Unaudited net assets as at 31 August 2021 were GBP3.798mln.

Afarak Group PLC (LSE:AFRK) said its speciality segment output showed net signs of improvement in the third quarter of 2021 but production overall was lower compared to a year ago mainly due to the divestment of major South African assets. Total production was 31,568Mt (43,121Mt).

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) said it is well-funded and expects to deliver progress on its candidate pipeline over the next year and a half.

Bradda Head Lithium Ltd (AIM:BHL) has received positive initial results from the GPRplus geophysical programme at the company’s Burro Creek and Wikieup projects in Arizona.

Power Metal Resources PLC (AIM:POW) said its final licence application at the Wallal project E45/5853 (Wallal West 1) has now been granted. Adding Wallal West 1 means that the entire Wallal project land package has been granted, which covers the Western, Eastern and Border anomalies.

Versarien, the advance materials engineering group, notes the media speculation regarding an ongoing market sounding. The Company confirms that it is has no intention to conduct a placing at this time.

Power Metal Resources PLC (AIM:POW) has signed a revised agreement for the 100% acquisition of First Development Resources Pty. Consideration for the acquisition is roughly GBP720,000, mostly to be met with the issue of new shares.


Please enter your comment!
Please enter your name here